VolitionRX Ltd. | |
Stock Exchange | NYSE |
EPS |
$0.53 |
Market Cap |
$122.79 M |
Shares Outstanding |
39.48 M |
Public Float |
22.41 M |
Address |
1 Scotts Road Singapore CE 228208 Singapore |
Employees | - |
Website | http://www.volitionrx.com |
Updated | 07/08/2019 |
VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore. |